{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:30:49Z","timestamp":1780731049564,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ajog.2016.07.013","type":"journal-article","created":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T20:01:08Z","timestamp":1468353668000},"page":"622.e1-622.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Nonresponse to 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention: clinical prediction and generation of a risk scoring system"],"prefix":"10.1016","volume":"215","author":[{"given":"Tracy A.","family":"Manuck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Stoddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C.","family":"Fry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Sean","family":"Esplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Varner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2016.07.013_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ajog.2014.12.011","article-title":"Why the United States preterm birth rate is declining","volume":"213","author":"Schoen","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.07.013_bib2","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3109\/14767058.2011.597899","article-title":"Preterm birth aetiology 2004-2008. Maternal factors associated with three phenotypes: spontaneous preterm labour, preterm pre-labour rupture of membranes and medically indicated preterm birth","volume":"25","author":"Henderson","year":"2012","journal-title":"J\u00a0Maternal-Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2016.07.013_bib3","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.283.12.1591","article-title":"Rates of and factors associated with recurrence of preterm delivery","volume":"283","author":"Adams","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2016.07.013_bib4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/AOG.0b013e318184181a","article-title":"Estimating recurrence of spontaneous preterm delivery","volume":"112","author":"Esplin","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.07.013_bib5","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/1471-0528.12182","article-title":"Risk factors for recurrent preterm birth in multiparous Utah women: a historical cohort study","volume":"120","author":"Simonsen","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2016.07.013_bib6","doi-asserted-by":"crossref","first-page":"576.e1","DOI":"10.1016\/j.ajog.2007.01.039","article-title":"Recurrence risk for preterm delivery","volume":"196","author":"McManemy","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.07.013_bib7","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2016.07.013_bib8","doi-asserted-by":"crossref","first-page":"321.e1","DOI":"10.1016\/j.ajog.2014.01.013","article-title":"Pharmacogenomics of 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention","volume":"210","author":"Manuck","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.07.013_bib9","doi-asserted-by":"crossref","first-page":"135.e1","DOI":"10.1016\/j.ajog.2011.03.048","article-title":"Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproate","volume":"205","author":"Manuck","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.07.013_bib10","doi-asserted-by":"crossref","first-page":"376.e1","DOI":"10.1016\/j.ajog.2015.12.010","article-title":"Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth","volume":"214","author":"Manuck","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.07.013_bib11","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ajog.2005.05.077","article-title":"Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery","volume":"193","author":"Spong","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.07.013_bib12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/AOG.0b013e3181cbd60e","article-title":"Omega-3 fatty acid supplementation to prevent recurrent preterm birth: a randomized controlled trial","volume":"115","author":"Harper","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.07.013_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/AOG.0b013e318202b2ef","article-title":"Cytokine gene polymorphisms and length of gestation","volume":"117","author":"Harper","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.07.013_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/01.AOG.0000103994.75162.16","article-title":"Asthma during pregnancy","volume":"103","author":"Dombrowski","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.07.013_bib15","first-page":"379","article-title":"Recurrence of preterm birth in singleton and twin pregnancies","volume":"98","author":"Bloom","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.07.013_bib16","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1002\/sim.4509","article-title":"Classification accuracy and cut point selection","volume":"31","author":"Liu","year":"2012","journal-title":"Stat Med"},{"key":"10.1016\/j.ajog.2016.07.013_bib17","series-title":"Regression modeling strategies with applications to linear models, logistic regression, and survival analysis","author":"Harrell","year":"2001"},{"key":"10.1016\/j.ajog.2016.07.013_bib18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/AOG.0b013e3181d53b83","article-title":"Progesterone receptor genotype, family history, and spontaneous preterm birth","volume":"115","author":"Manuck","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.07.013_bib19","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1213\/ANE.0000000000000705","article-title":"Outcomes for extremely premature infants","volume":"120","author":"Glass","year":"2015","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ajog.2016.07.013_bib20","doi-asserted-by":"crossref","first-page":"426.e1","DOI":"10.1016\/j.ajog.2014.01.046","article-title":"Correlation between initial neonatal and early childhood outcomes following preterm birth","volume":"210","author":"Manuck","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.07.013_bib21","doi-asserted-by":"crossref","first-page":"394.e1","DOI":"10.1016\/j.ajog.2015.12.034","article-title":"Racial disparity in previable birth","volume":"214","author":"DeFranco","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.07.013_bib22","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/jama.2015.10244","article-title":"Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012","volume":"314","author":"Stoll","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2016.07.013_bib23","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ajog.2015.12.002","article-title":"17 Alpha-hydroxyprogesterone caproate for preterm prevention: issues in subgroup analysis","volume":"214","author":"Klebanoff","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.07.013_bib24","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ajog.2012.03.010","article-title":"Progesterone and preterm birth prevention: translating clinical trials data into clinical practice","volume":"206","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.07.013_bib25","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/AOG.0b013e3182723b1b","article-title":"Gynecologists. Practice bulletin no. 130: prediction and prevention of preterm birth","volume":"120","year":"2012","journal-title":"Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937816304471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937816304471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:10:50Z","timestamp":1757589050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937816304471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0002937816304471"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2016.07.013","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726507653.793534028","asserted-by":"object"}]},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonresponse to 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention: clinical prediction and generation of a risk scoring system","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2016.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}